Ken Cacciatore
Stock Analyst at TD Cowen
(0.27)
# 4,002
Out of 4,789 analysts
14
Total ratings
25%
Success rate
-30.5%
Average return
Main Sectors:
Stocks Rated by Ken Cacciatore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics | Maintains: Outperform | $65 → $50 | $14.98 | +233.78% | 2 | Aug 9, 2023 | |
| BHC Bausch Health Companies | Downgrades: Market Perform | n/a | $6.25 | - | 1 | Jun 16, 2023 | |
| TAK Takeda Pharmaceutical Company | Maintains: Outperform | $30 → $20 | $14.90 | +34.23% | 4 | May 16, 2023 | |
| SCPH scPharmaceuticals | Initiates: Outperform | $25 | $2.33 | +972.96% | 1 | Dec 1, 2022 | |
| BLCO Bausch + Lomb | Initiates: Outperform | $35 | $14.10 | +148.23% | 1 | May 11, 2022 | |
| MOLN Molecular Partners AG | Initiates: Outperform | $50 | $3.84 | +1,202.08% | 1 | Jul 13, 2021 | |
| TARA Protara Therapeutics | Initiates: Outperform | $50 | $4.01 | +1,146.88% | 1 | Oct 19, 2020 | |
| BHVN Biohaven | Initiates: Outperform | $45 | $22.60 | +99.12% | 1 | Apr 17, 2020 | |
| AMRN Amarin Corporation | Initiates: Outperform | $23 | $0.44 | +5,103.62% | 1 | Mar 2, 2020 | |
| OPTN OptiNose | Initiates: Outperform | $375 | $9.15 | +3,998.36% | 1 | Dec 18, 2019 |
Arcutis Biotherapeutics
Aug 9, 2023
Maintains: Outperform
Price Target: $65 → $50
Current: $14.98
Upside: +233.78%
Bausch Health Companies
Jun 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $6.25
Upside: -
Takeda Pharmaceutical Company
May 16, 2023
Maintains: Outperform
Price Target: $30 → $20
Current: $14.90
Upside: +34.23%
scPharmaceuticals
Dec 1, 2022
Initiates: Outperform
Price Target: $25
Current: $2.33
Upside: +972.96%
Bausch + Lomb
May 11, 2022
Initiates: Outperform
Price Target: $35
Current: $14.10
Upside: +148.23%
Molecular Partners AG
Jul 13, 2021
Initiates: Outperform
Price Target: $50
Current: $3.84
Upside: +1,202.08%
Protara Therapeutics
Oct 19, 2020
Initiates: Outperform
Price Target: $50
Current: $4.01
Upside: +1,146.88%
Biohaven
Apr 17, 2020
Initiates: Outperform
Price Target: $45
Current: $22.60
Upside: +99.12%
Amarin Corporation
Mar 2, 2020
Initiates: Outperform
Price Target: $23
Current: $0.44
Upside: +5,103.62%
OptiNose
Dec 18, 2019
Initiates: Outperform
Price Target: $375
Current: $9.15
Upside: +3,998.36%